Franklin Resources
SLDB icon

Franklin Resources’s Solid Biosciences SLDB Stock Holding History

Franklin Resources’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.8M Buy
2,192,937
+593,704
+37% +$3.81M ﹤0.01% 1076
2025
Q4 		$9.02M Buy
1,599,233
+1
+0% +$5 ﹤0.01% 1193
2025
Q3 		$9.87M Buy
1,599,232
+59
+0% +$345 ﹤0.01% 1171
2025
Q2 		$7.79M Buy
1,599,173
+358,473
+29% +$1.27M ﹤0.01% 1213
2025
Q1 		$4.59M Buy
+1,240,700
New +$5.31M ﹤0.01% 1374
2022
Q4 		– Sell
-9,712
Closed -$68K – 2376
2022
Q3 		$68K Buy
9,712
+6,291
+184% +$63.4K ﹤0.01% 2166
2022
Q2 		$32K Sell
3,421
-1,659
-33% -$17.2K ﹤0.01% 2280
2022
Q1 		$91K Hold
5,080
– – ﹤0.01% 2311
2021
Q4 		$133K Hold
5,080
– – ﹤0.01% 2303
2021
Q3 		$182K Buy
+5,080
New +$216K ﹤0.01% 2251

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Franklin Resources's SLDB Position: Q1 2026 in Review

Franklin Resources increased its Solid Biosciences (SLDB) stake by 37% in Q1 2026, buying an estimated $3.81M and bringing the position to 2,192,937 shares worth $15.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1076.

Franklin Resources first reported a position in SLDB in Q3 2021 and has held it in 10 quarters since. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Franklin Resources held 2,192,937 shares of Solid Biosciences worth $15.8M as of Q1 2026.
  • Franklin Resources bought 593,704 Solid Biosciences shares in Q1 2026, an estimated $3.81M.
  • Solid Biosciences made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #1076 holding.
  • Franklin Resources first reported a position in Solid Biosciences in Q3 2021 and has held it in 10 quarters since.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.